Redeye comments on the new study showing that ColdZyme reduces viral load by more than 99% when applied onto human cells infected with influenza A. We argue the results are positive from a marketing perspective as well as it reduces the questions regarding ColdZyme’s effect. We reiterate our base case of SEK6.5.
LÄS MER